Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

NCT06950697 · clinicaltrials.gov ↗

RECRUITING

Status

2400

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Venous Thromboembolism
Arterial Thromboembolism
Immune Checkpoint Inhibitors (ICIs)

Sponsor

Beijing Chao Yang Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]